Lung volumes predict survival in patients with chronic lung allograft dysfunction

被引:35
作者
Kneidinger, Nikolaus [1 ]
Milger, Katrin [1 ]
Janitza, Silke [2 ]
Ceelen, Felix [1 ]
Leuschner, Gabriela [1 ]
Dinkel, Julien [3 ]
Koenigshoff, Melanie [4 ]
Weig, Thomas [5 ]
Schramm, Rene [6 ]
Winter, Hauke [7 ]
Behr, Juergen [1 ]
Neurohr, Claus [1 ]
机构
[1] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Dept Internal Med 5, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Med Informat Biometry & Epidemiol, Munich, Germany
[3] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Inst Clin Radiol, Munich, Germany
[4] German Ctr Lung Res DZL, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr CPC M, Res Unit Lung Repair & Regenerat, Munich, Germany
[5] Univ Munich, Dept Anaesthesiol, Munich, Germany
[6] Univ Munich, Clin Cardiac Surg, Munich, Germany
[7] Univ Munich, Dept Thorac Surg, Munich, Germany
关键词
BRONCHIOLITIS OBLITERANS SYNDROME; THIN-SECTION CT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; TRANSPLANTATION; HYPERINFLATION; MORTALITY; ONSET;
D O I
10.1183/13993003.01315-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Identification of disease phenotypes might improve the understanding of patients with chronic lung allograft dysfunction (CLAD). The aim of the study was to assess the impact of pulmonary restriction and air trapping by lung volume measurements at the onset of CLAD. A total of 396 bilateral lung transplant recipients were analysed. At onset, CLAD was further categorised based on plethysmography. A restrictive CLAD (R-CLAD) was defined as a loss of total lung capacity from baseline. CLAD with air trapping (AT-CLAD) was defined as an increased ratio of residual volume to total lung capacity. Outcome was survival after CLAD onset. Patients with insufficient clinical information were excluded (n=95). Of 301 lung transplant recipients, 94 (31.2%) developed CLAD. Patients with R-CLAD (n=20) and AT-CLAD (n=21), respectively, had a significantly worse survival (p<0.001) than patients with non-R/AT-CLAD. Both R-CLAD and AT-CLAD were associated with increased mortality when controlling for multiple confounding variables (hazard ratio (HR) 3.57, 95% CI 1.39-9.18; p=0.008; and HR 2.65, 95% CI 1.05-6.68; p=0.039). Furthermore, measurement of lung volumes was useful to identify patients with combined phenotypes. Measurement of lung volumes in the long-term follow-up of lung transplant recipients allows the identification of patients who are at risk for worse outcome and warrant special consideration.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction
    January, Spenser E.
    Fester, Keith A.
    Bain, Karen Bennett
    Kulkarni, Hrishikesh S.
    Witt, Chad A.
    Byers, Derek E.
    Alexander-Brett, Jennifer
    Trulock, Elbert P.
    Hachem, Ramsey R.
    CLINICAL TRANSPLANTATION, 2019, 33 (10)
  • [22] Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction
    Ram, Sundaresh
    Verleden, Stijn E.
    Bell, Alexander J.
    Hoff, Benjamin A.
    Labaki, Wassim W.
    Murray, Susan
    Vanaudenaerde, Bart M.
    Vos, Robin
    Verleden, Geert M.
    Kazerooni, Ella A.
    Galban, Stefanie
    Hatt, Charles R.
    Han, Meilan K.
    Lama, Vibha N.
    Galban, Craig J.
    CELLS, 2022, 11 (04)
  • [23] Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients
    Siddiqui, Atif S.
    Kumar, Gagan
    Majumdar, Tilottama
    Graviss, Edward A.
    Nguyen, Duc T.
    Goodarzi, Ahmad
    Kaleekal, Thomas
    CLINICAL TRANSPLANTATION, 2018, 32 (10)
  • [24] Early chest CT abnormalities to predict the subsequent occurrence of chronic lung allograft dysfunction
    Habert, Paul
    Chetrit, Elsa
    Coiffard, Benjamin
    Bregeon, Fabienne
    Thomas, Pascal
    Loundou, Anderson
    Bermudez, Julien
    Reynaud-Gaubert, Martine
    Gaubert, Jean-Yves
    INSIGHTS INTO IMAGING, 2023, 14 (01)
  • [25] Molecular Profiling in Lung Biopsies of Human Pulmonary Allografts to Predict Chronic Lung Allograft Dysfunction
    Jonigk, Danny
    Izykowski, Nicole
    Rische, Johanna
    Braubach, Peter
    Kuehnel, Mark
    Warnecke, Gregor
    Lippmann, Torsten
    Kreipe, Hans
    Haverich, Axel
    Welte, Tobias
    Gottlieb, Jens
    Laengert, Florian
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (12) : 3178 - 3188
  • [26] Acute Rejection and Chronic Lung Allograft Dysfunction Obstructive and Restrictive Allograft Dysfunction
    Beeckmans, Hanne
    Bos, Saskia
    Vos, Robin
    Glanville, Allan R.
    CLINICS IN CHEST MEDICINE, 2023, 44 (01) : 137 - 157
  • [27] Update on Chronic Lung Allograft Dysfunction
    Gauthier J.M.
    Hachem R.R.
    Kreisel D.
    Current Transplantation Reports, 2016, 3 (3) : 185 - 191
  • [28] Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction
    Gautschi, Fiorenza
    Vogelmann, Tobias
    Ortmanns, Gernot
    Knoerr, Fabian
    Steinack, Carolin
    Hage, Rene
    Naegeli, Mirjam
    Schuurmans, Mace Matthew
    JOURNAL OF CLINICAL APHERESIS, 2024, 39 (03)
  • [29] Chronic lung allograft dysfunction: light at the end of the tunnel?
    Verleden, Stijn E.
    Vos, Robin
    Verleden, Geert M.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2019, 24 (03) : 318 - 323
  • [30] The potential of biomarkers of fibrosis in chronic lung allograft dysfunction
    van der Ploeg, Eline A.
    Melgert, Barbro N.
    Burgess, Janette K.
    Gan, C. Tji
    TRANSPLANTATION REVIEWS, 2021, 35 (03)